The effect of preservative-free HP-Guar on dry eye after phacoemulsification: a flow cytometric study.
Sánchez
M A
MA
Department of Ophthalmology, Hospital Clínico San Carlos, Madrid, Spain.
Arriola-Villalobos
P
P
Torralbo-Jiménez
P
P
Girón
N
N
de la Heras
B
B
Herrero Vanrell
R
R
Alvarez-Barrientos
A
A
Benítez-del-Castillo
J M
JM
D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D015703:Antigens, CD / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism; D003228:Conjunctiva / Q000187:drug effects / Q000378:metabolism; D003315:Cornea / Q000187:drug effects; D003907:Dexamethasone / Q000627:therapeutic use; D015352:Dry Eye Syndromes / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D005260:Female; D005434:Flow Cytometry; D006684:HLA-DR Antigens / Q000378:metabolism; D006801:Humans; D008297:Male; D009883:Ophthalmic Solutions / Q000494:pharmacology*; D018918:Phacoemulsification / Q000009:adverse effects*; D011134:Polysaccharides / Q000494:pharmacology*; D011446:Prospective Studies; D013666:Tears / Q000502:physiology; D014031:Tobramycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D015703:Antigens, CD; D015415:Biomarkers; D006684:HLA-DR Antigens; D009883:Ophthalmic Solutions; D011134:Polysaccharides; C519976:hydroxypropyl guar; D003907:Dexamethasone; D014031:Tobramycin